Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
6Customers
2Debt Items
7Related Chains
Source-Backed Evidence Depth
Bullfrog AI Holdings, Inc. (BFRG) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
3Distinct source URLs
7High confidence
0.810Average confidence
2026-07-01Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Bullfrog AI Holdings, Inc. Suppliers
Ticker
Name
Confidence
Evidence
JHU-APL
JHU-APL
90%
In consideration of the new license, we issued 39,879 shares of common stock to JHU-APL
Bullfrog AI Holdings, Inc. Customers
Ticker
Name
Confidence
Evidence
CLIENT
CLIENT
92%
Pursuant to the Agreement, the Company will apply its proprietary methodology and artificial intelligence and machine learning tool, bfLEAP®, to discover and provide the Client with prioritized drug …
ELEISON-PHARMACEUTICALS-INC
ELEISON-PHARMACEUTICALS-INC
92%
The collaboration agreement, which was entered into in February 2025 and designed to enhance clinical trial efficacy, extract actionable insights from historical and ongoing data and improve strategi…
JHU-APL
JHU-APL
80%
JHU-APL will be entitled to eight percent (8%) of net sales for the services provided by us to other parties
BACKGROUND-BULLFROG-AI-HOLDINGS-INC
BACKGROUND-BULLFROG-AI-HOLDINGS-INC
62%
ination of factors, or factors we are unaware of, may cause actual results to differ materially from those contained in any forward-looking statements. You are cautioned not to place undue reliance o…
BTIG-LLC
BTIG-LLC
62%
025, we entered into a collaboration agreement with Eleison Pharmaceuticals Inc. (“Eleison”), a Phase 3 oncology company focused on novel chemotherapeutic treatments for rare cancers, and we recogniz…
LINCOLN-PARK-CAPITAL-FUND-LLC
LINCOLN-PARK-CAPITAL-FUND-LLC
62%
025, we entered into a collaboration agreement with Eleison Pharmaceuticals Inc. (“Eleison”), a Phase 3 oncology company focused on novel chemotherapeutic treatments for rare cancers, and we recogniz…
Bullfrog AI Holdings, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
BFRG-DEBT-8159
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2023-12-31.
BFRG-DEBT-8158
Warrants outstanding: 13661
90%
xbrl warrant detail from xbrl 2024-12-31.
Bullfrog AI Holdings, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Bullfrog AI Holdings, Inc..
Bullfrog AI Holdings, Inc. Ownership
Holder
Name
Confidence
Evidence
BFRG-OWNER-J-SAFRA-SARASIN-HOLDING-AG
J. Safra Sarasin Holding AG
90%
13F overlay lists J. Safra Sarasin Holding AG as top holder; 19 tracked holders.
Bullfrog AI Holdings, Inc. Extended Supply Chain Network
